[1]王永闯 肖兴军.氧化应激在周围神经病变发病机制中的作用[J].卒中与神经疾病杂志,2016,23(01):73-75.[doi:10.3969/j.issn.1007-0478.2016.01.023]
点击复制

氧化应激在周围神经病变发病机制中的作用()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第23卷
期数:
2016年01期
页码:
73-75
栏目:
综 述
出版日期:
2016-03-01

文章信息/Info

作者:
王永闯 肖兴军
作者单位:150081 哈尔滨医科大学附属第二医院神经内科[王永闯 肖兴军(通信作者)] 氧化应激在周围神经病变发病机制中的作用
分类号:
R745
DOI:
10.3969/j.issn.1007-0478.2016.01.023
文献标志码:
A

参考文献/References:

[1] PERSSON T, POPESCU B, CEDAZO-MINGUEZ A. Oxidative stress in Alzheimer's disease:why did antioxidant therapy fail[Z], 2014,2014: 427318.
[2] PISOSCHI A M, POP Aneta. The role of antioxidants in the chemistry of oxidative stress: A review[J]. European Journal of Medicinal Chemistry, 2015, 97(97): 55-74.
[3] Godic A, Poljsak B, Adamic M, et al. The role of antioxidants in skin cancer prevention and treatment[J]. Oxid Med Cell Longev. 2014,2014:860479.
[4] POLJSAK B, SUPUT D, MILISAV I. Achieving the balance between ROS and antioxidants:when to use the synthetic antioxidants[Z].Oxid Med Cell Longev, 2013: 956792.
[5] TESFAYE S, Selvarajah D. Advances in the epidemiology,pathogenesis and management of diabetic peripheral neuropathy[Z]. Diabetes-Metabolism research and reviews, 2012: 8-14.
[6] TESFAYE S, BOULTON A J, DYCK P J, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments[J]. Diabetes Care, 2010, 33(10): 2285-2293.
[7] Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress: therapeutic perspectives[J]. Oxid Med Cell Longev. 2013,2013:168039.
[8] ROLO AP. Palmeira,Diabetes and Mitochondrial Function:Role of Hyperglycemia and Oxidative Stress[J].Toxicolog yand Applied Pharmacology, 2006, 212(2): 167-178.
[9] Negi G, Kumar A, Joshi RP, et al. Oxidative stress and diabetic neuropathy: current status of antioxidants[J].Institute of Integrative Omics and Applied Biotechnology,2011,2(6):71-78.
[10] Takeuchi M, Takino J, Yamagishi S. Involvement of the toxic AGEs(TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy[J]. Curr Drug Targets. 2010,11(11):1468-1482.
[11] Vincent AM, Perrone L, Sullivan KA, et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress[J]. Endocrinology. 2007,148(2):548-558.
[12] TRIPATHI D N. Neuroinflammation and oxidative stress in diabetic neuropathy:futuristic strategies based on these targets[Z]. Int-J-Endocrinol, 2014: 674987.
[13] Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities[J]. Br J Clin Pharmacol. 2012,73(3):348-362.
[14] Tiwari V, Kuhad A, Chopra K. Neuroprotective effect of vitamin E isoforms against chronic alcohol-induced peripheral neurotoxicity: possible involvement of oxidative-nitrodative stress[J]. Phytother Res. 2012,26(11):1738-1745.
[15] Maiya RP, Messing RO. Peripheral systems: neuropathy[J]. Handb Clin Neurol,2014,125:513-525.
[16] KANDHARE AD, RAYGUDE KS, GHOSH P, et al. Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals[J]. Neuroscience Letters, 2012, 511(1): 18-22.
[17] KIM JK, KOH YD, KIM JS, et al. Oxidative stress in subsynovial connective tissue of idiopathic carpal tunnel syndrome[J]. Orthop Res, 2010, 28(11): 1463-1468.
[18] Demirkol A, Uludag M, Soran N, et al. Total oxidative stress and antioxidant status in patients with carpal tunnel syndrome[J]. Redox Rep. 2012,17(6):234-238.
[19] LIU R-m, PRAVIA K. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis[J]. Free Radical Biology and Medicine, 2010, 48(1): 1-15.
[20] LEE R, MARGARITIS M, CHANNON KM, et al. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations[J]. Current Medicinal Chemistry, 2012, 19(16): 2504-2520.
[21] SHIRI R, HELIÖVAARA M, MOILANEN L, et al. Associations of cardiovascular risk factors,carotid intima-media thickness and manifest atherosclerotic vascular disease with carpal tunnel syndrome[Z]. BMC Musculoskelet Disard,2011,12: 80.
[22] FERRIER J, PEREIRA V, BUSSEROLLES J, et al. Emerging trends in understanding chemotherapy-induced peripheral neuropathy[J]. Current Pain and Headache Reports, 2013, 17(10): 364.
[23] Wang XM, Lehky TJ, Brell JM, et al. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy[J]. Cytokine. 2012,59(1):3-9.
[24] ARETI A, YERRA VG, NAIDU V, et al. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy[J]. Redox Biology, 2014, 2(2): 289-295.
[25] TA LE, SCHMELZER JD, BIEBER AJ, et al. A novel and selective poly(ADP-ribose)polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy[J]. PLOS One, 2013, 8(1): e54161.
[26] WANG P, XIE K, WANG C, et al. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis[J]. European Neurology, 2014, 72(3/4): 249-254.

更新日期/Last Update: 1900-01-01